Trials / Active Not Recruiting
Active Not RecruitingNCT04947735
CYPRESS Efficacy and Safety Study Extension
Control of Myopia Using Peripheral Diffusion Lenses: Efficacy and Safety Study Extension
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- SightGlass Vision, Inc. · Industry
- Sex
- All
- Age
- 6 Years – 17 Years
- Healthy volunteers
- Accepted
Summary
This is an open-label, controlled, multisite, two-arm parallel group clinical trial of 36-month duration to evaluate the continued safety and efficacy of SightGlass Vision Diffusion Optics Technology (DOT) Spectacles in reducing the progression of juvenile myopia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Novel spectacle lens design | Use of single vision, impact resistant spectacle lenses may reduce the rate of progression of juvenile myopia |
| DEVICE | Spectacle lenses | Single vision, impact resistant spectacle lenses |
Timeline
- Start date
- 2021-07-19
- Primary completion
- 2025-04-30
- Completion
- 2026-03-31
- First posted
- 2021-07-01
- Last updated
- 2024-12-20
Locations
12 sites across 2 countries: United States, Canada
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04947735. Inclusion in this directory is not an endorsement.